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Abstract 
Objective:  to compare the efficacy of letrozole and clomiphene citrate in terms of pregnancy achievement and 
in anovulatory infertile women. Study Design: A randomized controlled trial. Place and Duration:  study 
conducted at the department of obstetrics and gynaecology DG Khan Teaching Hospital. DG Khan from March 
2017 to March 2018. Methodology: Two hundred and ten patients were included in this study. The patients were 
equally divided into two Groups as Group A and Group B by random number method. Study was started after 
permission from hospital ethical committee. Study variables were age and duration of infertility. SPSS version 
24 was used to analyze data. T test and chi square test were applied and p≤0.05 was taken as significant.  
Results: the mean age and duration of infertility of Group B was 25.66±3.39 years and 3.72±2.01 years, 
respectively. There were 73.3% patients between 18-30 years and 26.7% in 31-40 years of age. There were 79% 
patients had <5 years of duration of infertility and 21% had >5 years of duration of infertility. The difference was 
statistically significant (p=0.000) for age. The efficacy of Group A and B was observed as 16.2% and 45.7%, 
respectively. The difference was statistically significant, (p=0.000). Conclusion: use of Letrzole is safe and 
more effective for achieving pregnancy in anovulatory infertile women as compared to clomiphene citrate. 
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Introduction: 
Ovulation is a biochemical mechanism which results in maturation process of egg in the hypothalamic pituitary 
ovarian (HPO) axis1. Ovulation is orchestrated via neuro endocrine system and terminates in the ovary. Failure 
of the ovulation process is the main cause of reproductive failure or infertility in the infertile couples2. Frequency 
of this disorder is about 30 to 40% in infertile women. Ovulation induction therapy like fertility medication 
should target the HPO axis for successful outcome3.  
Letrozole and clomiphene citrate are two main drugs commonly used drug in ovulation induction therapy4. Many 
injectible medicines are also available like menopuror, follistim, repronex and gonil f which can be used 
intrauterine insemination. This process also named as in vitro fertilization5. Used of oral fertility drugs are most 
common and successful ovarian disfunction therapy. Ovarian stimulation can be increased by endogenous 
gonadotropin through antagonising the negative response of estrogen hormone at the level of hypothalamus with 
clomiphene citrate which is a selective estrogen receptor modulator6,7.  
Clomiphene also has some disadvantages like high multiple pregnancy rate, overall poor efficacy and some 
adverse effects like hot flashes and mood swings8. Another useful drug is letrozole which converts the endrogens 
by activating the arometaseenzyme and blocks the estrogen senses, letrozole directly affect the pituitary gland in 
the hypothalamic area and interfere with ovarian function and enhance the rate of pregnancy9. Letrozole have 
advantages of less side effects, low multiple pregnancy rate and mood swings with fewer vasomotor effect and 
early clearance10,11.  
In this study we aim to compare the efficacy of clomiphene and letrozole for ovulation and induction of 
pregnancy in anovulatory infertile women.  
Methodology: 
This is a randomized controlled trial was conducted at the department of obstetrics and gynaecology DG Khan 
Teaching Hospital. DG Khan from March 2017 to March 2018. All anovulatory infertile women having age limit 
18 to 40 years were included in the study and females with previous pelvic surgery, hyperprolactenemia, 
hypothyroidism (on the basis of history and medical record) and patients allergic to study drugs were excluded 
from the study. Non probability consecutive sampling technique was used. Patients having sexual intercourse 
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more than one year without any contraceptive pills by lateral normal tubal patency, normal pelvic 
ultrasonography and healthy male factor were labeled as anovulatory infertility.  
Efficacy was assessed by measuring the beta HCG after fifth day of missed menstrual cycle if beta HCG levels is 
more than or equal to 5 mIU/ ml after fifth day was labelled as yes otherwise no. Patients were divided into two 
equal groups (A and B) by random number method. Patients in group A were given clomiphene citrate by oral 
once a day for five days up to five menstrual cycles. Patients in group B were given letrozole 2.5mg once a day 
by oral up to five menstrual cycles. All patients were evaluated to see the occurrence of pregnancy after 
complete of every cycle by measuring the beta HCG cycle at fifth day and efficacy was noted. 
All the recorded data was entered in the computer software SPSS version 23. Mean and standard deviation were 
calculated for numerical data like age. Frequency and percentages were calculated for qualitative data like 
effectiveness. Student t test and chi square test were applied to see the association among variables. P value less 
than or equal to 0.05 was considered as significant.  
Results: 
 Two hundred and ten patients were included in this study. The patients were equally divided into two 
Groups as Group A=105 and Group B=105 by random number method. The mean age and duration of infertility 
of Group A was 28.25±4.77 years and 4.01±1.87 years, respectively. There were n=51 (48.6%) patients between 
18-30 years and n=54 (51.4%) in 31-40 years of age. There were n=88 (83.8%) patients had <5 years of duration 
of infertility and n=17 (16.2%) had >5 years of duration of infertility. While, the mean age and duration of 
infertility of Group B was 25.66±3.39 years and 3.72±2.01 years, respectively. There were n=77 (73.3%) 
patients between 18-30 years and n=28 (26.7%) in 31-40 years of age. There were n=83 (79%) patients had <5 
years of duration of infertility and n=22 (21%) had >5 years of duration of infertility. The difference was 
statistically significant (p=0.000) for age.(Table. I). 
The efficacy of Group A and B was observed as n=17 (16.2%) and n=48 (45.7%), respectively. The 
difference was statistically significant, (p=0.000). (Table. II). 
Table. I 
Demographic characteristics among the groups 
Variables Group A 
n=105 
Group B 
n=105 
P-value 
Age (years) 28.25±4.77 25.66±3.39 0.000 
Duration of infertility (years) 4.01±1.87 3.72±2.01 0.321 
Stratified age 
18-30 years n=51 (48.6%) n=77 (73.3%) 0.000 
31-40 years n=54 (51.4%) n=28 (26.7%) 
Stratified duration of infertility 
<5 years n=88 (83.8%) n=83 (79%) 0.375 
>5 years n=17 (16.2%) n=22 (21%) 
Table. II 
Efficacy among the groups 
Variables Group A 
n=105 
Group B 
n=105 
P-value 
Yes n=17 (16.2%) n=48 (45.7%) 0.000 
No n=88 (83.8%) n=57 (54.3%) 
 
Discussion: 
In our study we observed that letrozole is more efficacious and better in terms of achievement of pregnancy in 
infertile females who were selected for treatment of an ovulation. Our result shows effectiveness of clomephene 
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citrate 16.96% and letrozole group shows 33.04% with p value of 0.005 which is a significant value. Another 
similar study was conducted by Ibrahim et al12 in 2012 and reported 23.07% pregnancy achievement with the use 
of letrozole and 10.68% with the use of clomiphene citrate. This study was comparable with our study having 
almost all variables similar to our study. 
Another similar study was conducted by Seyedoshohadaei et al13 and shows 73.4% ovulation with use of 
clomiphene citrate and 78% with the use of tamoxifen and letrozole shows efficacy 74%. Rate of pregnancy 
achievement was 64% ,40%, and 50% in group A, B and C respectively. This study is also similar to our study 
which shows a better efficacy of clomiphene citrate in achievement of ovulation in infertile women. According 
to this study an ovulation is a main contributing factor in infertility of female gender.  
Another study was conducted by Atay et al14 in 2006 and reported that pregnancy achievement is much higher 
with use of letrozole when compared with clomiphene citrate. Results of this study were statistically significant. 
Another similar study was conducted by Bayar et al15 and reported that there was not significant difference in 
pregnancy rate in both groups when letrozole and clomiphene citrate were compared in terms of ovulation and 
pregnancy achievement goals. Both these studies were similar to our study and can be compared.  
A study was conducted by Kar et al16 on successful ovulation rate of letrozole and clomiphene and reported that 
clomiphene citrate gives 60.78% ovulation rate and letrozole shows 73.08% ovulation rate but these values were 
not statistically significant as p value is 0.39. Another study was conducted by Roy et al17 on comparison of 
clomiphene citrate and letrozole for achievement of pregnancy and observed effectiveness of letrozole is such 
higher 43.8% and compared with clomiphene citrate 26.4%. Both these studies were identical to our study and 
can be compared with our study.  
Hussain et al18 also conducted a study in 2013 and compared letrozole and clomiphene citrate and shows 25.3% 
pregnancy rate in letrozole group and 16% in clomephene citrate. Here is another study conducted by Parihar M 
et al19 and reported 11.9% pregnancy rate in letrozole group and 8.8% in clomiphene citrate.  
Another similar study was conducted by Naeem A et al20 and reported that Letrozole is bore effective in terms of 
preganacy achievemrnt when compared with Clomiphene citrate. Anovulatory is a rising issue in the medical 
history and should be considered with greater effort and considerations. Results of this study are also similar to 
our study and can be compared with results.  
Conclusion: our results reveal that use of Letrzole is safe and more effective for achieving pregnancy in 
anovulatory infertile women as compared to clomiphene citrate.  
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